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Summary
OBJECTIVE: Nitric oxide (NO) regulates arterial pressure
by modulating peripheral vascular tone and sympathetic
vasoconstrictor outflow. NO synthesis is impaired in sever-
al major cardiovascular disease states. Loss of NO-induced
vasodilator tone and restraint on sympathetic outflow could
result in exaggerated pressor responses to mental stress.
METHODS: We, therefore, compared the sympathetic
(muscle sympathetic nerve activity) and haemodynamic re-
sponses to mental stress performed during saline infusion
and systemic inhibition of NO-synthase by NG-
monomethyl-L-arginine (L-NMMA) infusion.
RESULTS: The major finding was that mental stress which
during saline infusion increased sympathetic nerve activity
by ~50 percent and mean arterial pressure by ~15 percent
had no detectable sympathoexcitatory and pressor effect
during L-NMMA infusion. These findings were not related
to a generalised impairment of the haemodynamic and/
or sympathetic responsiveness by L-NMMA, since the
pressor and sympathetic nerve responses to immersion of
the hand in ice water were preserved during L-NMMA in-
fusion.
CONCLUSION: Mental stress causes pressor and sym-
pathoexcitatory effects in humans that are mediated by NO.
These findings are consistent with the new concept that, in
contrast to what has been generally assumed, under some
circumstances, NO has a blood pressure raising action in
vivo.
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Introduction
Nitric oxide (NO), which is synthesised from the amino
acid L-arginine by the enzyme NO-synthase, plays an im-
portant role in the regulation of vasomotor tone and arterial
pressure in both animals and humans [1–4]. NO regulates
arterial pressure by a local action on peripheral vascular
tone and by modulating sympathetic vasoconstrictor out-
flow [5–12]. NO synthesis and/or release is defective in
patients with cardiovascular diseases such as hypercholes-
terolemia, hypertension, and heart failure [13–17] as well
as normal aging [17]. It has been hypothesised that the
conjunction of impaired NO-induced sympathoinhibition
and loss of NO-induced vasodilation could lead to aug-
mented sympathetic and pressor responses to mental stress
that could trigger acute cardiovascular events [18]. We,
therefore, examined the haemodynamic and sympathetic
responses to mental stress during systemic inhibition of
NO-synthase by NG-monomethyl-L-arginine (L-NMMA, a
competitive stereospecific inhibitor of NO-synthase) infu-
sion in healthy volunteers, and compared these responses
with those observed during an equipressor infusion of the
NO-independent vasoconstrictor phenylephrine and those
observed during vehicle infusion. Finally, to test for the
specificity of the findings, we studied the effects of D-
and L-arginine infusion after the L-NMMA infusion on the
haemodynamic and sympathetic responses to mental stress,
and we examined the haemodynamic responses to immer-
sion of the hand in ice water during L-NMMA infusion.
Methods
Subjects
We studied 13 healthy male volunteers (mean [±SD]
weight 72 ± 9 kg, height 180 ± 7 cm, body mass index 22.3
± 2.9 kg/m2, age 28 ± 3 years). All the subjects were nor-
motensive, were taking no medications, and had no evid-
ence of cardiovascular disease. All the studies were per-
formed in the morning after an overnight fast. The experi-
mental protocol was approved by the Institutional Review
Board on Human Investigation, and all subjects provided
written informed consent.
General procedures
The subjects were studied in the supine position. Heart rate,
respiratory excursions (pneumobelt), blood pressure (Fin-
apres), blood flow in the forearm and calf, and efferent
muscle sympathetic nerve activity were recorded continu-
ously on an electrostatic recorder and a tape recorder. Res-
piratory excursions were monitored to detect inadvertent
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performance of a Valsalva maneuver or prolonged expir-
ation, since these manoeuvres can stimulate sympathetic
outflow [19]. Drugs were infused through an intravenous
catheter inserted in an antecubital vein.
Mental stress
Mental stress was elicited by 4 minutes of a mental arith-
metic task [20]. The arithmetic task consisted of orally sub-
tracting a two digit from a four digit number. The stress was
maintained throughout the task by pressing the subjects to
speed their performance, and by frequently presenting new
arithmetic problems.
Recording of sympathetic-nerve activity
Multiunit recordings of postganglionic sympathetic nerve
activity were obtained with unipolar tungsten microelec-
trodes inserted selectively into muscle nerve fasciculi of
the peroneal nerve posterior to the fibular head by the mi-
croneurographic technique of Vallbo et al. [21]. The neur-
al signals were amplified 20 000 to 50 000 times, filtered
(bandwidth 700 to 2000 Hz), rectified and integrated (time
constant 0.1 s) to obtain a mean voltage display of sym-
pathetic activity. A recording of sympathetic activity was
considered acceptable when it revealed spontaneous, pulse
synchronous bursts of neural activity, with the largest
bursts showing a minimal signal to noise ratio of 3:1. In
each study, we documented that we were recording sym-
pathetic outflow to skeletal muscle by demonstrating that
the neural activity did not respond to arousal stimuli (loud
noise) or a pinch of the skin, but showed a characteristic
biphasic response to the Valsalva manoeuvre [19].
For analysis, printed filtered and mean voltage neuro-
grammes were visually inspected to identify bursts of sym-
pathetic nerve discharge. The recordings were all analysed
by the same observer who was blinded to the pharmacolo-
gical intervention assigned to the subject. The intraobserv-
er and interobserver coefficients of variation of the mean
in identifying bursts are less than 6 percent and less than
9 percent, respectively [22]. Nerve traffic was expressed as
number of bursts per minute, an index of the frequency of
the activity.
Measurement of muscle blood flow
While recording sympathetic outflow to calf muscles in
one leg, we simultaneously measured blood flow in the
contra lateral leg and forearm by venous occlusion
plethysmography using mercury-in-Silastic strain gauges
[19]. The forearm and calf were elevated 10 to 15 cm above
the level of the right atrium to collapse the veins. Circula-
tion to the hand and the foot was arrested by inflating a cuff
around the wrist and the ankle during blood flow determin-
ations.
Drugs
Drugs were dissolved in physiological saline immediately
before use. L-NMMA, L- and D-arginine were obtained
from Clinalfa (Läufelfingen, Switzerland), and phenyleph-
rine from Winthrop Pharmaceuticals.
Experimental protocols
Protocol 1
After instrumentation the subjects rested quietly for 30
min. They then received sequential infusions of normal sa-
line (1 ml/min) for 30 min, and L-NMMA (50 μg/kg/min)
for 60 min. In each of the 13 subjects, we measured the
haemodynamic and sympathetic responses to two 4 min
periods of mental stress; one was performed during saline
infusion, and one 45 min after the start of the L-NMMA in-
fusion. At the end of each stress, the subjects were asked to
rate their perceived stress on a scale of 6 (minimal stress)
to 20 (maximal stress) as a subjective index of stress.
To examine whether the findings were related specifically
to NO-synthase inhibition, 5 of the subjects received ad-
ditional sequential infusions of D-arginine (50 mg/kg over
10 min), and L-arginine (50 mg/kg over 10 min) after the
L-NMMA infusion. Two additional bouts of mental stress
were performed 5 minutes after the end of each, the D-, and
the L-arginine infusion.
Haemodynamic measurements and sympathetic nerve
activity were recorded during two 5-minute periods of sa-
line infusion, from minute 35 to 45 after the start of L-
NMMA infusion, (and the 5 minutes following the arrest of
the D- and L-arginine infusions, n = 5), as well as during
the two (four) 4-minute-bouts of mental stress.
On a separate occasion, 8 of the subjects underwent two
bouts of mental stress at a 1-hour interval during saline in-
fusion to examine the potential effects of habituation on the
haemodynamic responses to mental stress. Haemodynamic
responses were comparable during the two tests; during the
last minute of the mental stress, mean arterial pressure had
increased by 8.5 ± 2.8 and by 8.0 ± 1.9 mm Hg, and heart
rate by 13 ± 3 and 12 ± 2 beats/min during the first and the
second test, respectively.
Protocol 2
To examine the effects of the augmented baseline arterial
pressure during L-NMMA infusion on the haemodynamic
responses to mental stress, in 6 subjects, we examined
the haemodynamic responses to mental stress performed
45 minutes after the start of phenylephrine infusion (ti-
trated at a rate to match the increase in baseline arterial
pressure observed during the L-NMMA studies).
Protocol 3
To examine whether the findings were specific for mental
stress, on a separate day, we measured in 6 of the subjects,
sympathetic and haemodynamic responses during a 2 min
immersion of the hand in ice water; one test was performed
during saline infusion (1 ml/min), the other 30 min after the
start of L-NMMA infusion (50 μg/kg/min).
Data analysis
Mean arterial pressure was calculated as diastolic pressure
plus 1/3 pulse pressure. The measurements of muscle sym-
pathetic nerve activity (MSNA), heart rate and mean arter-
ial pressure that were collected over 5-minute periods were
averaged to a single value.
Statistical analysis was performed with paired two-tailed t-
tests and an analysis of variance with repeated measures
followed by Fisher’s post hoc test. A value of P <0.05 was
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considered significant. Data are given as mean ± SE unless
stated otherwise.
Results
Table 1 shows that the mental stress induced increase in
arterial pressure was diminished by L-NMMA infusion.
This effect was not related to the augmented baseline ar-
terial pressure during L-NMMA infusion, since the pressor
response to mental stress was preserved during an equi-
Figure 1
Mean ± SE effects in 5 normal subjects of mental stress on heart
rate, mean arterial pressure, and muscle sympathetic nerve activity
(MSNA) during saline infusion, and during NG-monomethyl-L-
arginine (L-NMMA) infusion followed by D-arginine (D-Arg) and L-
arginine (L-Arg) infusion. Bars represent the mean changes from
baseline over the 4 minutes of mental stress. L-arginine (but not D-
arginine) infusion restored the haemodynamic and sympathetic
responses to mental stress. *P <0.05, vs. saline infusion.
pressive phenylephrine infusion (mean arterial pressure in-
creased by 12% during saline infusion, by 3% during L-
NMMA infusion, and by 13% during phenylephrine in-
fusion, P <0.01, L-NMMA vs. phenylephrine). L-NMMA
infusion also attenuated the heart rate response throughout
the mental stress; during the first minute of the stress heart
rate increased from 62 ± 3 to its peak value of 81 ± 3 beats/
min during saline infusion, and from 58 ± 3 to 71 ± 3 beats/
min during L-NMMA infusion (P <0.001, L-NMMA vs.
saline). L-NMMA did not alter the subjective perception of
the mental stress; the rates of perceived stress were 13 ± 1
and 14 ± 1, during saline and L-NMMA infusion, respect-
ively.
To test for potential underlying mechanisms that could be
involved in the altered heamodynamic responsiveness to
mental stress during L-NMMA infusion, we examined the
sympathetic nerve responses in the calf vasculature. As ex-
pected, during saline infusion, mental stress increased sym-
pathetic nerve activity and induced a transient reduction of
limb vascular resistance during the first 2 minutes of the
stress. Table 1 and figure 1 show that L-NMMA dimin-
ished the mental stress induced sympathetic activation. The
L-NMMA induced suppression of the sympathetic activ-
ation in the calf vasculature was associated with the per-
sistence of the vasodilation in the calf during the last two
minutes of the mental stress (P <0.02 vs. saline, table 1).
The lack of sympathetic activation was not related to a
generalised impairment of the sympathetic responsiveness,
since L-NMMA infusion did not alter the sympathetic re-
sponse to the cold pressor test. During the second minute of
immersion of the hand in ice water, the rate of sympathetic
nerve firing had increased from 19 ± 3 to 25 ± 4 bursts/min
during saline infusion, and from 21 ± 3 to 26 ± 3 bursts/
min during L-NMMA infusion, mean arterial pressure in-
creased from 78 ± 2 to 86 ± 2 and from 81 ± 3 to 89 ±
2 mm Hg, respectively, and heart rate increased from 61
± 4 to 68 ± 4 and from 59 ± 3 to 68 ± 4 beats/min, re-
spectively. Finally, we examined whether during L-NMMA
infusion, the altered haemodynamic response could be re-
lated to augmented stimulation of epinephrine release. We
found that mental stress increased (P = 0.04) plasma epi-
nephrine levels from 19 ± 2 pg/ml at baseline to values
that were comparable during saline (31 ± 5 pg/ml) and L-
NMMA (36 ± 5 pg/ml) infusion.
Figure 1 shows that during L-NMMA infusion, the alter-
ations of the cardiovascular and sympathetic responses to
mental stress were related specifically to inhibition of NO
synthesis, since they persisted during D-arginine infusion,
but were reversed by L-arginine infusion.
Table 1: Effects of L-NMMA infusion on cardiovascular and sympathetic responses to mental stress.
Mental stress plus saline infusion Mental stress plus L-NMMA infusion
Baseline 1' 2' 3' 4' Baseline L-NMMA 1' 2' 3' 4'
Heart rate (beats/min) 62 ± 3 81 ± 3* 74 ± 3* 73 ± 3* 75 ± 3* 64 ± 3 58 ± 3* 71 ± 3‡ 67 ± 3‡ 67 ± 2‡ 66 ± 3‡
Mean arterial pressure (mm Hg) 78 ± 4 85 ± 4* 89 ± 4* 88 ± 4* 88 ± 4* 78 ± 3 84 ± 3† 84 ± 4 87 ± 5 87 ± 6 87 ± 5
Forearm vascular resistance (U) 32 ± 2 22 ± 2* 28 ± 2† 31 ± 2 30 ± 5 33 ± 2 35 ± 3 26 ± 2‡ 26 ± 2‡ 27 ± 2‡ 26 ± 3‡
Calf vascular resistance (U) 46 ± 5 39 ± 4† 36 ± 4† 46 ± 5 43 ± 5 48 ± 5 44 ± 3 35 ± 3§ 38 ± 4§ 38 ± 3‡ 37 ± 4§
MSNA (bursts/min) 16 ± 2 23 ± 3† 24 ± 3* 24 ± 3* 28 ± 3* 18 ± 2 19 ± 2 15 ± 2 15 ± 2 17 ± 2 15 ± 2
L-NMMA: NG-monomethyl-L-arginine; MSNA: muscle sympathetic nerve activity
Values are mean ± SE for 13 subjects, except for MSNA (n = 10) and calf blood flow and vascular resistance (n = 8)
*P <0.01 vs corresponding baseline; †P <0.05 vs corresponding baseline; ‡P <0.01 vs L-NMMA alone; §P <0.05 vs L-NMMA alone.
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Discussion
We found that mental stress which during saline infusion
markedly increased mean arterial pressure and muscle
sympathetic nerve activity had no detectable effect on these
two variables during L-NMMA infusion. The attenuation
of the blood pressure response was not related to the L-
NMMA-induced increase of baseline arterial pressure, be-
cause an equipressive infusion of the non-endothelium de-
pendent vasoconstrictor phenylephrine did not attenuate
the pressor response to mental stress. These findings
provide direct evidence for a rise in blood pressure and
sympathoexcitatory action of NO in vivo.
The lack of mental stress-induced haemodynamic and sym-
pathetic responses during L-NMMA infusion was not re-
lated to habituation, since the haemodynamic responses to
two consecutive bouts of stress during saline infusion were
comparable, and, most importantly, the haemodynamic and
sympathetic responses were restored when the stress was
repeated after L-arginine infusion. The attenuated sympath-
etic and haemodynamic responses also cannot be attrib-
uted to a non-specific attenuation of the subjective per-
ception of the psychological stress by L-NMMA, as evid-
enced by similar rates of perceived stress during saline
and L-NMMA infusion. The findings cannot be explained
by altered adrenomedullary responsiveness, since, in line
with a previous report [23], epinephrine levels were com-
parable during saline and L-NMMA infusion. Finally, the
findings were not related to a non-specific impairment of
the haemodynamic and/or sympathetic responsiveness by
L-NMMA, since the responses to immersion of the hand in
ice water were preserved during L-NMMA infusion.
Sympathetic and vascular responses to mental stress are
highly differentiated. For example, whereas in the leg sym-
pathetic activation has been a universal finding [24–26], in
the arm, sympathetic activity remains unchanged [24] or
may even decrease [27] during mental stress. A previous
study reported decreased norepinephrine levels during L-
NMMA infusion at baseline and during mental stress that
could have been related to altered sympathetic outflow and/
or altered norepinephrine release or clearance [23]. Here,
we used direct recordings of sympathetic nerve activity
to address this issue. While as expected, L-NMMA infu-
sion did not alter sympathetic outflow at rest [9] it sup-
pressed mental stress-induced sympathetic activation in the
leg. This suppression of the mental stress-induced sym-
pathetic activation by L-NMMA was associated with per-
sistent vasodilation in the calf that may have contributed to
the attenuated pressor response. Moreover, L-NMMA infu-
sion also attenuated the heart rate response to mental stress,
even though the smaller increase in arterial pressure pre-
sumably resulted in removal of baroreflex restraint on the
chronotropic response. Since this response is thought to be,
at least in part, sympathetically mediated [28], and sym-
pathetic nerve responses in the leg are correlated with nore-
pinephrine spillover in the heart [29], L-NMMA may also
have attenuated the mental stress-induced cardiac sympath-
etic activation, an effect which may have contributed to the
attenuated blood pressure response. In line with this hy-
pothesis, a decreased cardiac output-dependent increase in
blood pressure has been suggested to contribute to the at-
tenuated blood pressure response to mental stress during L-
NMMA infusion [23]. Alternatively, inhibition of NO syn-
thesis by a 3-min bolus infusion of much larger doses of
L-NMMA was found to alter baroreflex control of heart
rate during simulated orthostatic stress [30]. We did not as-
sess baroreflex function in the present studies and cannot
exclude the possibility that in the present study, prolonged
infusion of much lower doses of L-NMMA also altered
baroreflex control of heart rate and, in turn may have con-
tributed to altered heart rate responses to mental stress. Fin-
ally, it is possible that L-NMMA may also suppress the
mental stress-induced sympathetic activation and vasocon-
striction in other regions, such as the visceral vascular bed.
In mice, systemic injection of a NO-synthase inhibitor sup-
presses central neural NO-synthase activity as early as
15 minutes after its administration [31]. Moreover, NO has
an excitatory action on neurons of the nucleus tractus solit-
arius in rats [8], and renal sympathetic preganglionic neur-
ons in rabbits [5]. Finally, NO derived from neuronal NO-
synthase has been suggested to increase arterial pressure
in intact endothelial NO-synthase knockout mice by stimu-
lating sympathetic activity [31]. Taken together with these
findings in experimental animals, our data in conscious hu-
mans could be consistent with the hypothesis that, under
some conditions, central neural NO increases arterial pres-
sure by stimulating sympathetic nerve activity.
Importantly, the observation that L-NMMA did not alter
the sympathoneural and haemodynamic response to the
cold pressor test in the present, nor those to exercise in an
earlier study [9], suggests that NO has differential effects
on sympathetic and cardiovascular responsiveness to dif-
ferent forms of stress in humans.
Previous studies using local intraarterial L-NMMA infu-
sion had suggested that NO, while contributing to the vas-
odilator response to mental stress in the forearm circula-
tion, plays a modest role in the circulatory adaptation to
mental stress in healthy subjects [32–34]. The present find-
ings in conjunction with previously published data [23]
challenge this concept and indicate that NO plays an im-
portant role in mediating the blood pressure and heart rate
adjustments to mental stress which appear to be mediated,
at least in part, by NO-induced sympathetic activation.
Moreover, our data are consistent with the hypothesis that
defective NO synthesis may have differential regional ef-
fects on the vascular responsiveness to mental stress, since
in the coronary circulation, endothelial dysfunction has
been shown to disturb the normal vasodilator response res-
ulting in paradoxical vasoconstriction during mental stress
[35], whereas in the present studies, we found that NO-
synthase inhibition resulted in persistent limb vasodilation
(and lack of a blood pressure response) throughout the en-
tire period of mental stress. Finally, in the clinical setting
defective NO synthesis has been consistently shown in
pathological conditions characterised by endothelial dys-
function such as hypertension, obesity, dyslipidemia,
insulin-resistance, heart failure as well as normal aging
[13–17]. The present findings could suggest that in these
subjects autonomic and cardiovascular adjustments to men-
tal stress may be altered similarly as those observed during
L-NMMA infusion in healthy humans.
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Figures (large format)
Figure 1
Mean ± SE effects in 5 normal subjects of mental stress on heart rate, mean arterial pressure, and muscle sympathetic nerve activity (MSNA)
during saline infusion, and during NG-monomethyl-L-arginine (L-NMMA) infusion followed by D-arginine (D-Arg) and L-arginine (L-Arg) infusion.
Bars represent the mean changes from baseline over the 4 minutes of mental stress. L-arginine (but not D-arginine) infusion restored the
haemodynamic and sympathetic responses to mental stress. *P <0.05, vs. saline infusion.
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